Combination immunotherapy + VEGF targeted therapy is the optimal systemic strategy for metastatic RCC

Combination immunotherapy + VEGF targeted therapy is the optimal systemic strategy for metastatic RCC

User Photo
kidneycancer

5 years
1,046 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Elizabeth R. Plimack MD MS Director, Genitourinary Clinical Research Associate Professor, Department of Hematology/Oncology discusses Combination immunotherapy + VEGF targeted therapy is the optimal systemic strategy for metastatic RCC at the Kidney Cancer Meeting in Chiacgo
Up Next Autoplay